Ibrance (palbociclib) is a medication used for the treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer.


What is Ibrance (palbociclib)?

Ibrance is the brand name for the generic drug Palbociclib . This medicine belongs to a group of second-generation cyclin-dependent kinase inhibitor (CDK) 4/6 inhibitors.

Palbociclib is used in combination with letrozole (Femara) as initial endocrine therapy for the treatment of human epidermal growth factor receptor 2 (HER2) and hormone receptor (HR) positive breast tumors in adult cancer patients.

Palbociclib is developed by Pfizer for the treatment of cancer and there is no other generic medicine available on this drug.


21pills of 75mg, 21 pills of 100mg, 21 pills of 125mg


There are no reviews yet.

Be the first to review “Ibrance”

Your email address will not be published. Required fields are marked *

Shopping Cart